Graymark Appoints Jamie Hopping as Chairman of the Board

Monday, May 23, 2011 General News
Email Print This Page Comment bookmark
Font : A-A+

Health Services Veteran Brings 30 Years of Operational Experience in Hospital Facility Management

OKLAHOMA CITY, May 23, 2011 /PRNewswire/ -- Graymark Healthcare, Inc. (NASDAQ: GRMH), the nation's second largest provider

of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), has appointed Jamie Hopping as chairman of its board of directors, effective July 1, 2011. She will succeed Stanton Nelson, who will continue in his role as chief executive officer.

Hopping comes to Graymark as a 30-year health services veteran, serving in a variety of upper-level operational roles with major health care facility providers. Her extensive career includes serving as the western group president for HCA Holdings, where she was responsible for the finance and operations of 60 hospitals across 13 states and generating $4 billion in annual revenue. She was also previously the executive vice president and chief operating officer of Ardent Health Services, a $1 billion acute care hospital and specialty care facility employing more than 400 physicians.

"Jamie is an exceptional executive who brings valuable expertise in the health services field and a proven track record in driving operational success and revenue growth for hospital facilities across the U.S.," said Nelson. "Her business and operational acumen, in addition to her breadth of contacts in the health services industry, will prove invaluable as we continue to build market acceptance for our comprehensive model of diagnosing and treating OSA in the hospital setting."

Hopping commented: "For the some 50 million Americans suffering from sleep disorders, Graymark offers a unique and proven platform to help people in communities of all sizes, from urban to rural, who need and deserve our state-of-the-art diagnosis and treatments. The company's momentum in the hospital setting has accelerated over recent quarters, and this makes me both proud and excited to join the company at this pivotal stage of its development."

Graymark operates a growing number of sleep laboratories nationwide, comprised of 24 standalone or IDTF facilities in large communities and 74 hospital, provider or rural outreach sites. While the care environments may vary based on community need, Graymark ensures that the quality and comprehensiveness of the services provided remain consistently at the highest standard.

About Graymark Healthcare

Headquartered in Oklahoma City, Okla., Graymark Healthcare, Inc. (NASDAQ:GRMH) is the nation's second largest provider of sleep management solutions. In addition to diagnosing and treating over 80 sleep disorders, the company specializes in comprehensive care for Obstructive Sleep Apnea (OSA). Graymark offers its services through 98 sleep laboratories throughout the United States, including standalone or IDTF facilities, rural outreach sites and hospital or provider agreements. For more information, visit

Important Cautions Regarding Forward-Looking Statements

This press release may contain forward-looking statements that are based on the company's current expectations, forecasts and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the company, including, without limitation, the current economic climate and other risks and uncertainties, including those enumerated and described in the company's filings with the Securities and Exchange Commission, which filings are available on the SEC's website at Unless otherwise required by law, the company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Graymark Healthcare, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store